Cannabis and Hemp Industry Investment News
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires () updated investors on the company's swift progress sin...
Developing revolutionary injectable CBD delivery system Strategic partnership with Hebrew University to study Liposome Platform Technology Tie-up with...
A study on mice using Innocan's technology showed a “prolonged release” of CBD in the blood for “at least three weeks after one administration” Innoca...
Results indicated significant hydration increases for each two-, four-, eight, and 24-hour period after application The SHIR facial serum contains 300...
What are you searching for? viewInnoCan Pharma Analyst Toby Ma highlighted the Israeli company’s potential clinical, licensing and commercial catalyst...
The distribution agreement with Cloud 9 Switzerland LLC will see it sell Innocan’s SHIR Beauty and Relief & Go lines in the two countries The deal...
What are you searching for? viewInnoCan Pharma Innocan Pharma Corporation () CEO Iris Bincovich and Endless Sky CEO Travis George tells Proactive the ...
ESI will exclusively distribute Innocan’s CBD products in Canada and manufacture them at its facility in Saskatchewan Innocan’s products include its R...
The company said its products have “successfully" passed safety assessment in accordance with European Union cosmetic regulation No 1223/2009 CEO Iris...
InnoCan is working on a revolutionary exosome-based technology that targets both central nervous system indications and COVID-19 coronavirus symptoms ...
What are you searching for? viewInnoCan Pharma Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news t...
The pain relief formulation contains a combination of Magnesium oil, Methyl salicylate, Menthol and CBD About 1.5 billion people worldwide suffer from...
Recipharm unites more than 30 facilities across 10 different countries offering pharmaceutical development and manufacturing services Exosomes, extrac...
The debt is being settled through the issuance of 335,570 common shares to a former service provider at $0.149 each The company focuses on the develop...
The pharmaceutical tech group has developed several lines of skin cosmetic products InnoCan's contract manufacturer for the products Fancystage is in ...
InnoCan is working to develop a treatment that would utilize CBD-loaded exosomes to treat coronavirus in the lungs Israel-based Innocan Pharma is a sp...
Innocan’s largest shareholder Tamar Innovest purchased nearly 3.9 million units representing approximately 19.6% ownership of the company The financin...
What are you searching for? viewInnoCan Pharma Innocan Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive with news the company...
The Israel-based company said it plans to start shipping product internationally within two weeks nnoCan Pharma is a pharmaceutical tech company devel...
The company plans to use the proceeds for research and product development expenses, marketing expenses, and administrative expenses Innocan Pharma is...
